
COVID-19 Impact on Global Peptic Ulcer Drugs Market by Disease Indication (Gastric Ulcers, Duodenal Ulcers, and Esophageal Ulcers); By Application (Hospital Pharmacies, Drug Stores, Retail Stores and Online Sales) and Region –Analysis of Market Size, Shar
Description
COVID-19 Impact on Global Peptic Ulcer Drugs Market by Disease Indication (Gastric Ulcers, Duodenal Ulcers, and Esophageal Ulcers); By Application (Hospital Pharmacies, Drug Stores, Retail Stores and Online Sales) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
COVID-19 Impact on Global Peptic Ulcer Drugs Market by Disease Indication (Gastric Ulcers, Duodenal Ulcers, and Esophageal Ulcers); By Application (Hospital Pharmacies, Drug Stores, Retail Stores and Online Sales) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
COVID-19 Impact on Global Peptic Ulcer Drugs Market by Disease Indication (Gastric Ulcers, Duodenal Ulcers, and Esophageal Ulcers); By Application (Hospital Pharmacies, Drug Stores, Retail Stores and Online Sales) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
Table of Contents
- 1. Executive Summary
- 2. Peptic Ulcer Drugs Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3. Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4. Average Pricing Analysis
- 5. Market Dynamics
- 5.1. Growth Drivers
- 5.2. Restraints
- 5.3. Opportunity
- 5.4. Trends
- 6. Correlation & Regression Analysis
- 6.1. Correlation Matrix
- 6.2. Regression Matrix
- 7. Recent Development, Policies & Regulatory Landscape
- 8. Risk Analysis
- 8.1. Demand Risk Analysis
- 8.2. Supply Risk Analysis
- 9. Peptic Ulcer Drugs Market Analysis
- 9.1. Porters Five Forces
- 9.1.1. Threat of New Entrants
- 9.1.2. Bargaining Power of Suppliers
- 9.1.3. Threat of Substitutes
- 9.1.4. Rivalry
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Peptic Ulcer Drugs Market
- 10.1. Market Size & forecast, 2019A-2030F
- 10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11. Peptic Ulcer Drugs Market: Market Segmentation
- 11.1. By Regions
- 11.1.1. North America:(U.S. and Canada)
- 11.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
- 11.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
- 11.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
- 11.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
- 11.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12. Peptic Ulcer Drugs Market: Market Segmentation
- 12.1. By disease indication: Market Share (2020-2030F)
- 12.1.1. gastric ulcers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.2. duodenal ulcers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.3. esophageal ulcers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2. By application : Market Share (2020-2030F)
- 12.2.1. hospital pharmacies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2.2. drug stores, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2.3. retail store, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2.4. online sales, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 13. Company Profile
- 13.1. Eumedica
- 13.1.1. Company Overview
- 13.1.2. Company Total Revenue (Financials)
- 13.1.3. Market Potential
- 13.1.4. Global Presence
- 13.1.5. Key Performance Indicators
- 13.1.6. SWOT Analysis
- 13.1.7. Product Launch
- 13.2. Takeda Pharmaceutical Co. Ltd.
- 13.3. Taiho Pharmaceutical
- 13.4. Ferring Pharmaceuticals
- 13.5. PharmaKing
- 13.6. Zuventus Healthcare
- 13.7. Otsuka Holdings
- 13.8. Daiichi Sankyo
- 13.9. Johnson and Johnson
- 13.10. Other prominent players
- Consultant Recommendation
- **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.